Glaxo Wellcome
gsk.comTotal trials
72
Active
0
Phase 3
17
Total enrollment
6,704
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- HIV Infections72
- Pneumonia, Pneumocystis Carinii4
- Herpes Simplex4
- AIDS Dementia Complex2
- Leukoplakia, Hairy1
- Cytomegalovirus Infections1
- Lymphoma, Non-Hodgkin1
- Neuromuscular Diseases1
Frequently asked questions about Glaxo Wellcome
- How many clinical trials does Glaxo Wellcome have on ClinicalTrials.gov?
- Glaxo Wellcome is listed as the lead sponsor on 72 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Glaxo Wellcome's trials are in Phase 3?
- 17 of Glaxo Wellcome's trials are in Phase 3.
- What therapeutic areas does Glaxo Wellcome focus on?
- Glaxo Wellcome's most-studied conditions on ClinicalTrials.gov are HIV Infections, Pneumonia, Pneumocystis Carinii, Herpes Simplex, AIDS Dementia Complex, Leukoplakia, Hairy.